Method for treating a t-lymphocyte-mediated disease.

TN2025000049A1Undetermined Publication Date: 2026-10-01JOINT CO BIOCAD

0 Cites 0 Cited by

Patent Information

Application Number: TN2025000049P0
Authority / Receiving Office: TN · TN
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-02-18
Publication Date: 2026-10-01

Application Information

Patent Timeline

18 Feb 2025

Application

TN2025000049P0

01 Oct 2026

Publication

TN2025000049A1

Inventors: ZINKINA-ORIKHAN, Arina Valerievna; MOROZOVA, Mariia Andreevna

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to the field of medicine, and more particularly to a method for treating a disease or disorder mediated by T-lymphocytes bearing a TRBV9 segment within the T-cell receptor, which includes administering an anti-TRBV9 antibody in specific doses and dosage regimens, and further relates to the use of an anti-TRBV9 antibody to treat a disease or disorder mediated by T-lymphocytes bearing a TRBV9 segment within the T-cell receptor, where the anti-TRBV9 antibody is administered in specific doses and dosage regimens.

Need to check novelty before this filing date? Find Prior Art